- Slow traction clouding GSK-Dr Reddy's expansive deal?
- GSK plans to divest old drugs except in emerging markets
- US Capitol Capsule: Time to 'go big' on cures innovation, lawmakers declare
- New Takeda moves signal emerging markets intent
- INTERVIEW: Merck Serono's Belén Garijo on pricing, emerging markets and diversity
- INTERVIEW: Clinuvel's Philippe Wolgen on Scenesse and the patient factor